11 months ago

Blue Jet Healthcare Investors Await Margin Recovery

Blue Jet Healthcare Investors Await Margin Recovery
Blue Jet Healthcare investors await margin recovery amid rosy growth prospects · livemint.com

Blue Jet Healthcare's stock price has decreased recently.

The company makes ingredients for medical imaging and sweeteners, like saccharin.

The company is working to make more profitable products and cut costs by producing its own raw materials.

They are expanding their manufacturing capacity.

Over the past four years, revenue and profit have more than doubled.

Investors are now waiting to see if profit margins will improve again.

If the company succeeds in its plans, the stock may increase in value.

Key facts

Stock Price Decline
40% from 52-week high
52-Week High
₹1,027.80
EBITDA Margin (Q1FY26)
34%
Contract Manufacturing Focus
Contrast media intermediates and high-intensity sweeteners
Key Clients
GE Healthcare, Colgate-Palmolive, Unilever
Revenue FY25
₹1,030 crore
Profit After Tax FY25
₹305 crore
Capacity Increase
Planning to add another 1,000KL

Sources

Related news